NCT00372593
Clinical Trial Information
Trial Number: NCT00372593 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Leukemia - Acute Myeloid Leukemia
Trial Title:
A Phase III Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg) Combined With Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents, and Young Adults
Study ID:
AAML0531
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00372593-D3 | As of November 2019, there is one dataset associated with this publication (PMID 31113932). The D3 dataset is a patient level dataset which contains patient characteristics, genotypes for the SNP of interest, cytogenetic mutation, and outcome analyses for eligible pediatric acute myeloid leukemia (AML) patients enrolled on the AAML0531 clinical trial. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®